Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Tekla Capital Management

Tekla Capital Management

A venture capital firm in Boston that focuses on securities of public and private healthcare companies.

Tekla Capital Management is a venture capital firm in Boston that focuses on securities of public and private healthcare companies. Founded 1986 in Boston, Massachusetts, United States, this venture capital invests in early stage ventures and late stage ventures. Its portfolio companies include VectivBio, Arkuda Therapeutics, Amphivena Therapeutics, Oculis, Milestone Pharmaceuticals, CuraSen Therapeutics, Galera Therapeutics, Atreca, Therachon, and Sutro Biopharma. As of February 2020, Tekla Capital Management has made 26 investments. Their most recent investment was on January 8, 2020, when VectivBio raised $35M. Tekla Capital Management has had 14 exits, the most notable of which include Atreca, CytomX Therapeutics, and Sutro Biopharma.

Timeline

Invested in

Patents

Funding Rounds Participated In

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

News

Title
Author
Date
Publisher
Description
FinSMEs
July 27, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.

References

Golden logo
By using this site, you agree to our Terms & Conditions.